These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3922803)

  • 1. Effect of aromatase inhibition by delta 1-testolactone on basal and luteinizing hormone-releasing hormone-stimulated pituitary and gonadal hormonal function in oligospermic men.
    Dony JM; Smals AG; Rolland R; Fauser BC; Thomas CM
    Fertil Steril; 1985 May; 43(5):787-92. PubMed ID: 3922803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aromatase inhibition by delta 1-testolactone does not relieve the gonadotropin-induced late steroidogenic block in normal men.
    Smals AG; Dony JM; Smals AE; Pieters GF; Hermus AR; Boers GH; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1127-31. PubMed ID: 3923019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic aromatase inhibition by delta 1-testolactone on pituitary-gonadal function in oligozoospermic men.
    Dony JM; Smals AG; Rolland R; Fauser BC; Thomas CM
    Andrologia; 1986; 18(1):69-78. PubMed ID: 3082244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid control of gonadotropin secretion in the human male. I. Effects of testosterone administration in normal and gonadotropin-releasing hormone-deficient men.
    Finkelstein JS; Whitcomb RW; O'Dea LS; Longcope C; Schoenfeld DA; Crowley WF
    J Clin Endocrinol Metab; 1991 Sep; 73(3):609-20. PubMed ID: 1908484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effect of luteinizing hormone-releasing hormone infusion on testicular steroids in normal men and patients with idiopathic oligospermia.
    Dony JM; Smals AG; Rolland R; Fauser BC; Thomas CM
    Fertil Steril; 1984 Aug; 42(2):274-80. PubMed ID: 6430726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease.
    Dunaif A; Longcope C; Canick J; Badger T; Crowley WF
    J Clin Endocrinol Metab; 1985 Apr; 60(4):773-80. PubMed ID: 3919053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of delta 1-testolactone on the pituitary-testicular axis in oligospermic men.
    Vigersky RA; Glass AR
    J Clin Endocrinol Metab; 1981 May; 52(5):897-902. PubMed ID: 6785292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of testolactone on human testicular steroid production and on the response to human chorionic gonadotropin.
    Martikainen H; Ruokonen A; Rönnberg L; Vihko R
    Fertil Steril; 1985 May; 43(5):793-8. PubMed ID: 3922804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic efficacy of testolactone (aromatase inhibitor) to oligozoospermia with high estradiol/testosterone ratio].
    Itoh N; Kumamoto Y; Maruta H; Tsukamoto T; Takagi Y; Mikuma N; Nanbu A; Tachiki H
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):204-9. PubMed ID: 2041267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term therapy of oligozoospermia with the aromatase inhibitor testolactone].
    Schill WB; Reiter F; Korting HC; Schweikert HU
    Hautarzt; 1987 Jul; 38(7):395-9. PubMed ID: 3115914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of men with idiopathic oligozoospermic infertility using the aromatase inhibitor, testolactone. Results of a double-blinded, randomized, placebo-controlled trial with crossover.
    Clark RV; Sherins RJ
    J Androl; 1989; 10(3):240-7. PubMed ID: 2663800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feedback control of luteinizing hormone and follicle-stimulating hormone secretion by testosterone and estradiol in men: physiological and clinical implications.
    Santen RJ
    Clin Biochem; 1981 Oct; 14(5):243-51. PubMed ID: 6800671
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone.
    Zumoff B; Miller LK; Strain GW
    Metabolism; 2003 Sep; 52(9):1126-8. PubMed ID: 14506617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogens in the feedback regulation of gonadotropin secretion in men: effects of administration of estrogen to agonadal subjects and the antiestrogen tamoxifen and the aromatase inhibitor delta'-testolactone to eugonadal subjects.
    Gooren LJ; van der Veen EA; van Kessel H; Harmsen-Louman W
    Andrologia; 1984; 16(6):568-77. PubMed ID: 6440458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The luteinizing hormone-releasing hormone pulse generator in men: abnormalities and clinical management.
    Matsumoto AM; Gross KM; Sheckter CB; Bremner WJ
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1743-52. PubMed ID: 2122731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of clomiphene citrate on plasma levels of immunoreactive luteinizing hormone-releasing hormone, gonadotropin, and testosterone in normal subjects and in patients with idiopathic oligospermia.
    Masala A; Delitala G; Alagna S; Devilla L; Lotti G
    Fertil Steril; 1978 Apr; 29(4):424-7. PubMed ID: 348501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men.
    Dony JM; Smals AG; Rolland R; Fauser BC; Thomas CM
    Andrologia; 1985; 17(4):369-78. PubMed ID: 3931502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of delta 1-testolactone on serum testosterone and estradiol in the adult male rat.
    Nagler HM; deVere White R; Dyrenfurth I; Hembree WC
    Fertil Steril; 1983 Dec; 40(6):818-22. PubMed ID: 6653801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone.
    Feuillan PP; Foster CM; Pescovitz OH; Hench KD; Shawker T; Dwyer A; Malley JD; Barnes K; Loriaux DL; Cutler GB
    N Engl J Med; 1986 Oct; 315(18):1115-9. PubMed ID: 3093862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estradiol.
    Bagatell CJ; Dahl KD; Bremner WJ
    J Androl; 1994; 15(1):15-21. PubMed ID: 8188534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.